You are here

  • Home
  • Archive
  • Volume 19, Issue 1
  • Lower target oxygen saturation levels in preterm infants are associated with increased mortality and decreased rates of retinopathy of prematurity

Article Text

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Lower target oxygen saturation levels in preterm infants are associated with increased mortality and decreased rates of retinopathy of prematurity
  1. Daniele Trevisanuto,
  2. Veronica Mardegan
  1. Children's and Women's Health Department, University of Padua, Azienda Ospedaliera di Padova, Padova, Italy
  1. Correspondence to: Dr Daniele Trevisanuto, Children's and Women's Health Department, University of Padua, Azienda Ospedaliera Padova, Via Giustiniani, 3 Padova, 35128, Italy; trevo{at}pediatria.unipd.it

https://doi.org/10.1136/eb-2013-101463

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: BOOST II UK Collaborative Group; BOOST II Australia Collaborative Group; BOOST II New Zealand Collaborative Group, et al. Oxygen saturation and outcomes in preterm infants. N Engl J Med 2013;368:2094–104.OpenUrlCrossRefPubMedWeb of Science

    Context

    The goal of oxygen therapy is to deliver sufficient oxygen to the tissues while minimising oxygen toxicity and oxidative stress. Although many extremely preterm infants receive supplemental oxygen for prolonged periods, the optimal oxygen saturation has not yet been defined.

    Methods

    The Benefits Of Oxygen Saturation Targeting (BOOST) II randomised controlled trial (RCT) aimed to evaluate the effects of targeting an oxygen saturation of 85–89%, as compared with a range of 91–95%, on disability-free survival at 2 years in infants born before 28 weeks’ gestation. During the study period, two major changes were made to the original study protocol; first, in the midst of the UK and Australian trials, …

    View Full Text

    Footnotes

    • Competing interests None.